Research: UPU

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

PR Newswire

2009-09-24 16:00
Vikas Nanda, PhD, Earns New Innovator Award from NIH - Research May Impact Treatment of Cancer, Lupus and other Autoimmune Disorders

2009-09-22 20:00
The Lupus Foundation of America, Inc. Asks Supporters to Band Together for Lupus(SM)

2009-09-16 20:00
FDA Advisory Committee Unanimously Recommends Approval of XIAFLEX(TM) for Treatment of Dupuytren's Disease

2009-08-11 08:00
Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018

2009-08-07 16:00
The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs

2009-07-29 20:00
LFAGW to Offer First 'Living with Lupus' Baltimore Workshop on August 15

2009-07-20 00:00
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

2009-07-20 00:00
First Potential Lupus-Specific Treatment in Sight

2009-07-15 16:00
LFAGW to Run 'Could I Have Lupus?' Workshop on July 26; Mystics Game Follows

2009-07-09 16:00
Basic Facts and Statistics About Lupus

2009-07-08 12:00
Lupus Foundation of America Accepting Letters of Intent for Research Grants on Adult Stem Cell Research and Health-Related Quality of Life in Pediatric Lupus

2009-06-25 16:00
Summer Sun Peaks Flare-Ups for People with Lupus

2009-06-22 20:00
Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation

2009-06-11 08:00
Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

Pharmaceutical Business Review

2009-09-07 04:04
HGS Presents Results For Lupus Trial
Study evaluates Benlysta in serologically active patients with SLE

2009-09-04 12:04
BioSpecifics Technologies Reports Results For Phase III XIAFLEX CORD I Study
XIAFLEX, for the nonsurgical treatment of Dupuytren's disease

2009-08-03 12:03
Arthritis Advisory Committee Confirms Date To Review Xiaflex
Xiaflex, an orphan-designated biologic, for the treatment of Dupuytren's contracture

2009-08-03 04:03
FDA To Review Xiaflex For Treatment Of Dupuytren's Contracture
Review date scheduled for September 16, 2009

2009-06-12 12:04
HGS Provides Positive Results For Clinical Trial Of Lupus Drug
Benlysta, a human monoclonal antibody that specifically recognizes and inhibits the biological activity of BLyS

2009-07-20 00:02
Lupus Drug Revives Human Genome Sciences' Prospects
Benlysta is first new medicine to succeed against disease in 50 years.